## Note
nid: 1516062551867
model: AnKingOverhaul
tags: #AK_Original_Decks::Step_1::Zanki_Step_Decks::Zanki_Hematology_&_Oncology::RBC_Misc., #AK_Step1_v11::#B&B::11_Hematology::02_RBC::08_Blood_Groups, #AK_Step1_v11::#FirstAid::10_Hematology_Oncology::01_Embryology::03_Hemolytic_Disease_of_the_Newborn, #AK_Step1_v11::#FirstAid::10_Hematology_Oncology::01_Embryology::03_Hemolytic_Disease_of_the_Newborn::ABO_Hemolytic_Disease, #AK_Step1_v11::#OME_banner, #AK_Step1_v11::#UWorld::1000-9999::8000-8999::8261, #AK_Step1_v11::^Other::^EXPN::BGadd, #AK_Step1_v11::^Other::^FA_Updates::FA2018, #AK_Step1_v11::^Other::^HighYield::1-HighYield, #AK_Step1_v11::^Systems::HemeOnc::RBC::ABO/Rh
markdown: false

### Text
<b>ABO hemolytic disease of the newborn</b> has the potential to
occur when a <b>Type {{c1::O}} mother</b> has a <b>Type {{c1::A or
B}}</b> <b>fetus</b>

### Extra
<div>
  - Pre-existing antibodies cross the placenta and causes
  erythroblastosis fetalis
</div>
<div>
  - In <b>type A / B mothers</b>, pre-existing antibodies that
  develop with gut colonization as a newborn are almost always
  <b>IgM</b> (<u>cannot cross the placenta</u>); whereas in <b>type
  O mothers</b>, pre-existing antibodies that develop with gut
  colonization as a newborn have a much higher amount of <b>IgG</b>
  (<u>CAN cross the placenta</u>)
</div>

### Lecture Notes


### Missed Questions


### Pathoma


### Boards and Beyond


### First Aid


### Sketchy


### Pixorize


### Physeo


### OME
<div class="ome-widget">
  <a href="https://onlinemeded.org?ref=anki"><img src=
  "_OME_AnkiFlashcards_General_3.png"></a>
</div>

### Additional Resources


### One by one

